CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 25 enrolled
Drug / intervention
Control Intervention (UVB) +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04547998
NCT04547998N/ACompleted
CompareCT.gov

A Prospective Blinded Within-Subject Randomized Controlled Clinical Study to Investigate the Safety and Effectiveness of RECELL for Repigmentation of Stable Vitiligo Lesions

Avita Medical·interventional·Posted Sep 14, 2020·Updated May 24, 2024

In Brief

A clinical study evaluating Control Intervention (UVB) and Investigational Interventions (Ablative Laser Resurfacing + RECELL + UVB) for Vitiligo. Completed, enrolled 25 participants across 12 sites.

Detailed Summary

This is a prospective blinded within-subject randomized study to evaluate the application of Spray-On Skin™ Cells, prepared using the RECELL® Device for safe and effective repigmentation of ablated stable vitiligo lesions.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsVitiligo
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
202120222023202420252026
First PostedSep 14, 2020
Enrollment StartSep 10, 2020
Primary CompletionJun 28, 2022
Study CompletionJan 31, 2023
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 5.8 years ago

Interventions

Control Intervention (UVB)device

Targeted narrowband-UVB phototherapy in alignment with published Vitiligo Working Group recommendations.

Investigational Interventions (Ablative Laser Resurfacing + RECELL + UVB)device

Spray-On Skin™ Cells prepared using RECELL will be applied to an area prepared by ablative laser, followed by targeted narrowband UVB phototherapy.